HEADER TRANSFERASE/INHIBITOR 21-DEC-22 8FLL TITLE CRYSTAL STRUCTURE OF BTK KINASE DOMAIN IN COMPLEX WITH PIRTOBRUTINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE BTK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: AGAMMAGLOBULINEMIA TYROSINE KINASE,ATK,B-CELL PROGENITOR COMPND 6 KINASE,BPK,BRUTON TYROSINE KINASE; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BTK, AGMX1, ATK, BPK; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS BTK INHIBITOR, TRANSFERASE, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR E.P.CEDERVALL,T.H.MORALES,C.K.ALLERSTON REVDAT 4 12-JUL-23 8FLL 1 JRNL REVDAT 3 15-MAR-23 8FLL 1 AUTHOR REVDAT 2 08-MAR-23 8FLL 1 AUTHOR REMARK REVDAT 1 01-MAR-23 8FLL 0 JRNL AUTH E.B.GOMEZ,K.EBATA,H.S.RANDERIA,M.S.ROSENDAHL,E.P.CEDERVALL, JRNL AUTH 2 T.H.MORALES,L.M.HANSON,N.E.BROWN,X.GONG,J.STEPHENS,W.WU, JRNL AUTH 3 I.LIPPINCOTT,K.S.KU,R.A.WALGREN,P.B.ABADA,J.A.BALLARD, JRNL AUTH 4 C.K.ALLERSTON,B.J.BRANDHUBER JRNL TITL PRECLINICAL CHARACTERIZATION OF PIRTOBRUTINIB, A HIGHLY JRNL TITL 2 SELECTIVE, NONCOVALENT (REVERSIBLE) BTK INHIBITOR. JRNL REF BLOOD V. 142 62 2023 JRNL REFN ESSN 1528-0020 JRNL PMID 36796019 JRNL DOI 10.1182/BLOOD.2022018674 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.8 (8-JUN-2022) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 21.76 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 40700 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.202 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1957 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.51 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.62 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2455 REMARK 3 BIN FREE R VALUE : 0.2734 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 46 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2069 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 65 REMARK 3 SOLVENT ATOMS : 168 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.54 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.66160 REMARK 3 B22 (A**2) : -0.94640 REMARK 3 B33 (A**2) : 2.60800 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.180 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.080 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.075 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.077 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.073 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.955 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2290 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3123 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 796 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 402 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2290 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 290 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : 14 ; 1.000 ; HARMONIC REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2259 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.09 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 4.02 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 14.57 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -20.686 5.9956 -10.7168 REMARK 3 T TENSOR REMARK 3 T11: 0.0035 T22: -0.0229 REMARK 3 T33: -0.0198 T12: 0.0025 REMARK 3 T13: 0.0141 T23: -0.0077 REMARK 3 L TENSOR REMARK 3 L11: 0.4581 L22: 0.4463 REMARK 3 L33: 0.6491 L12: -0.0196 REMARK 3 L13: -0.1991 L23: -0.4503 REMARK 3 S TENSOR REMARK 3 S11: -0.0173 S12: 0.0123 S13: 0.0026 REMARK 3 S21: 0.0123 S22: -0.0397 S23: 0.0272 REMARK 3 S31: 0.0026 S32: 0.0272 S33: 0.057 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8FLL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-JAN-23. REMARK 100 THE DEPOSITION ID IS D_1000270951. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-JUN-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9793 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC V1.1.7 REMARK 200 DATA SCALING SOFTWARE : AUTOPROC V1.1.7 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40714 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.498 REMARK 200 RESOLUTION RANGE LOW (A) : 53.963 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 5.400 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.52 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.80 REMARK 200 R MERGE FOR SHELL (I) : 0.83500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.8.3 REMARK 200 STARTING MODEL: A PROPRIETARY MODEL OF SAME PROTEIN WITH ANOTHER REMARK 200 LIGAND REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 31% PEG3350, 0.3 M AMMONIUM SULFATE, REMARK 280 0.1 M BIS-TRIS PH 5.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.74100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.19150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.63450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 45.19150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.74100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.63450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 387 REMARK 465 MET A 388 REMARK 465 GLY A 389 REMARK 465 LEU A 390 REMARK 465 GLY A 391 REMARK 465 TYR A 392 REMARK 465 GLY A 393 REMARK 465 SER A 394 REMARK 465 SER A 659 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TRP A 395 CD1 CD2 NE1 CE2 CE3 CZ2 CZ3 REMARK 470 TRP A 395 CH2 REMARK 470 LYS A 400 CG CD CE NZ REMARK 470 LYS A 406 CE NZ REMARK 470 GLN A 412 CG CD OE1 NE2 REMARK 470 LYS A 433 CE NZ REMARK 470 GLU A 434 CD OE1 OE2 REMARK 470 ASP A 440 CG OD1 OD2 REMARK 470 GLU A 445 CG CD OE1 OE2 REMARK 470 LYS A 447 CG CD CE NZ REMARK 470 GLU A 455 CG CD OE1 OE2 REMARK 470 LYS A 466 CD CE NZ REMARK 470 ARG A 468 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 487 NE CZ NH1 NH2 REMARK 470 GLU A 488 CG CD OE1 OE2 REMARK 470 ARG A 492 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 496 CD OE1 NE2 REMARK 470 GLU A 500 CD OE1 OE2 REMARK 470 LYS A 558 CD CE NZ REMARK 470 LYS A 573 CD CE NZ REMARK 470 LYS A 595 CE NZ REMARK 470 GLU A 599 CG CD OE1 OE2 REMARK 470 ARG A 600 CD NE CZ NH1 NH2 REMARK 470 GLU A 608 CD OE1 OE2 REMARK 470 LYS A 625 CE NZ REMARK 470 LYS A 637 CD CE NZ REMARK 470 LYS A 645 CE NZ REMARK 470 ASP A 656 CG OD1 OD2 REMARK 470 GLU A 658 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 520 -12.98 82.20 REMARK 500 ASP A 521 51.47 -149.80 REMARK 500 REMARK 500 REMARK: NULL DBREF 8FLL A 389 659 UNP Q06187 BTK_HUMAN 389 659 SEQADV 8FLL GLY A 387 UNP Q06187 EXPRESSION TAG SEQADV 8FLL MET A 388 UNP Q06187 EXPRESSION TAG SEQRES 1 A 273 GLY MET GLY LEU GLY TYR GLY SER TRP GLU ILE ASP PRO SEQRES 2 A 273 LYS ASP LEU THR PHE LEU LYS GLU LEU GLY THR GLY GLN SEQRES 3 A 273 PHE GLY VAL VAL LYS TYR GLY LYS TRP ARG GLY GLN TYR SEQRES 4 A 273 ASP VAL ALA ILE LYS MET ILE LYS GLU GLY SER MET SER SEQRES 5 A 273 GLU ASP GLU PHE ILE GLU GLU ALA LYS VAL MET MET ASN SEQRES 6 A 273 LEU SER HIS GLU LYS LEU VAL GLN LEU TYR GLY VAL CYS SEQRES 7 A 273 THR LYS GLN ARG PRO ILE PHE ILE ILE THR GLU TYR MET SEQRES 8 A 273 ALA ASN GLY CYS LEU LEU ASN TYR LEU ARG GLU MET ARG SEQRES 9 A 273 HIS ARG PHE GLN THR GLN GLN LEU LEU GLU MET CYS LYS SEQRES 10 A 273 ASP VAL CYS GLU ALA MET GLU TYR LEU GLU SER LYS GLN SEQRES 11 A 273 PHE LEU HIS ARG ASP LEU ALA ALA ARG ASN CYS LEU VAL SEQRES 12 A 273 ASN ASP GLN GLY VAL VAL LYS VAL SER ASP PHE GLY LEU SEQRES 13 A 273 SER ARG TYR VAL LEU ASP ASP GLU TYR THR SER SER VAL SEQRES 14 A 273 GLY SER LYS PHE PRO VAL ARG TRP SER PRO PRO GLU VAL SEQRES 15 A 273 LEU MET TYR SER LYS PHE SER SER LYS SER ASP ILE TRP SEQRES 16 A 273 ALA PHE GLY VAL LEU MET TRP GLU ILE TYR SER LEU GLY SEQRES 17 A 273 LYS MET PRO TYR GLU ARG PHE THR ASN SER GLU THR ALA SEQRES 18 A 273 GLU HIS ILE ALA GLN GLY LEU ARG LEU TYR ARG PRO HIS SEQRES 19 A 273 LEU ALA SER GLU LYS VAL TYR THR ILE MET TYR SER CYS SEQRES 20 A 273 TRP HIS GLU LYS ALA ASP GLU ARG PRO THR PHE LYS ILE SEQRES 21 A 273 LEU LEU SER ASN ILE LEU ASP VAL MET ASP GLU GLU SER HET Y7W A 701 34 HET SO4 A 702 5 HET GOL A 703 6 HET GOL A 704 6 HET BTB A 705 14 HETNAM Y7W PIRTOBRUTINIB HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETNAM BTB 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL- HETNAM 2 BTB PROPANE-1,3-DIOL HETSYN Y7W 5-AMINO-3-{4-[(5-FLUORO-2-METHOXYBENZAMIDO) HETSYN 2 Y7W METHYL]PHENYL}-1-[(2S)-1,1,1-TRIFLUOROPROPAN-2-YL]-1H- HETSYN 3 Y7W PYRAZOLE-4-CARBOXAMIDE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN BTB BIS-TRIS BUFFER FORMUL 2 Y7W C22 H21 F4 N5 O3 FORMUL 3 SO4 O4 S 2- FORMUL 4 GOL 2(C3 H8 O3) FORMUL 6 BTB C8 H19 N O5 FORMUL 7 HOH *168(H2 O) HELIX 1 AA1 ASP A 398 LYS A 400 5 3 HELIX 2 AA2 SER A 438 GLU A 445 1 8 HELIX 3 AA3 GLU A 445 ASN A 451 1 7 HELIX 4 AA4 LEU A 482 ARG A 490 1 9 HELIX 5 AA5 GLN A 494 LYS A 515 1 22 HELIX 6 AA6 ALA A 523 ARG A 525 5 3 HELIX 7 AA7 GLY A 541 VAL A 546 5 6 HELIX 8 AA8 ASP A 548 SER A 553 1 6 HELIX 9 AA9 PRO A 560 SER A 564 5 5 HELIX 10 AB1 PRO A 565 SER A 572 1 8 HELIX 11 AB2 SER A 575 SER A 592 1 18 HELIX 12 AB3 THR A 602 GLN A 612 1 11 HELIX 13 AB4 SER A 623 CYS A 633 1 11 HELIX 14 AB5 LYS A 637 ARG A 641 5 5 HELIX 15 AB6 THR A 643 GLU A 658 1 16 SHEET 1 AA1 5 LEU A 402 GLY A 411 0 SHEET 2 AA1 5 GLY A 414 TRP A 421 -1 O TYR A 418 N LEU A 405 SHEET 3 AA1 5 TYR A 425 ILE A 432 -1 O ILE A 429 N LYS A 417 SHEET 4 AA1 5 PHE A 471 THR A 474 -1 O ILE A 472 N LYS A 430 SHEET 5 AA1 5 LEU A 460 CYS A 464 -1 N GLY A 462 O ILE A 473 SHEET 1 AA2 3 GLY A 480 CYS A 481 0 SHEET 2 AA2 3 CYS A 527 VAL A 529 -1 O VAL A 529 N GLY A 480 SHEET 3 AA2 3 VAL A 535 VAL A 537 -1 O LYS A 536 N LEU A 528 CISPEP 1 ARG A 468 PRO A 469 0 4.75 CRYST1 41.482 67.269 90.383 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024107 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014866 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011064 0.00000